Study finds frexalimab has favorable effect on relapsing multiple sclerosis
FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh
Updated on: March 28,2024
2
Study finds frexalimab has favorable effect on relapsing multiple sclerosis
FEBRUARY 15, 2024by Elana GotkineFor patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weigh
Updated on:March 28,2024
2